Sight Sciences Holds Annual Stockholders Meeting

An update from Sight Sciences ( (SGHT) ) is now available.

On April 21, 2025, Sight Sciences, Inc. appointed Gerhard F. Burbach to its Board of Directors and the Audit Committee. At the annual stockholders meeting on June 5, 2025, the company elected three Class I directors and ratified Deloitte & Touche LLP as its independent accounting firm for the fiscal year ending December 31, 2025. The meeting saw participation from approximately 75.1% of the company’s outstanding shares.

The most recent analyst rating on (SGHT) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on Sight Sciences stock, see the SGHT Stock Forecast page.

Spark’s Take on SGHT Stock

According to Spark, TipRanks’ AI Analyst, SGHT is a Neutral.

Sight Sciences’ overall stock score is primarily influenced by its strong technical analysis, indicating bullish momentum despite potential overbought conditions. Financial performance poses a significant risk with negative cash flow and declining revenues. Valuation concerns further impact the score due to ongoing losses. Mixed earnings call results highlight operational challenges and strategic initiatives in progress.

To see Spark’s full report on SGHT stock, click here.

More about Sight Sciences

Sight Sciences, Inc. operates in the medical technology industry, focusing on developing and commercializing innovative solutions for ophthalmology and optometry. The company is known for its products designed to address eye diseases, particularly those affecting the anterior segment of the eye.

Average Trading Volume: 217,451

Technical Sentiment Signal: Hold

Current Market Cap: $207.8M

Learn more about SGHT stock on TipRanks’ Stock Analysis page.